Atumelnant

· Crinetics Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Atumelnant, covering 2026-03-11 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia [Phase 3]